GLAM
RPTP

Gardner Lewis Asset Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Gardner Lewis Asset Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,941,012
Closed -$17.4M – 150
2016
Q3 		$17.4M Buy
+1,941,012
New +$13.8M 1.41% 21

Gardner Lewis Asset Management's RPTP Position: Q4 2016 in Review

Gardner Lewis Asset Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 1,941,012 shares — an estimated $17.4M sold.

Gardner Lewis Asset Management first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $17.4M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Gardner Lewis Asset Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 1,941,012 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $17.4M.
  • Gardner Lewis Asset Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • Gardner Lewis Asset Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $17.4M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.